Skip to content

    ACADIA PHARMACEUTICALS (ACAD) stock price & financials

    View ACAD earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+9.6% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $250.40M
    $259.60M
    $244.32M
    $264.57M
    $278.63M
    +11.3%
    $283.99M
    +9.4%
    $268.06M
    +9.7%
    $307.96M
    +16.4%
    Strengthening
    Operating Profit
    $31.64M
    $153.50M
    $19.29M
    $32.37M
    $35.76M
    +13.0%
    $17.39M
    -88.7%
    -$4.62M
    -123.9%
    $37.84M
    +16.9%
    Weakening
    Net Profit
    $32.77M
    $143.74M
    $18.99M
    $26.67M
    $71.78M
    +119.1%
    $273.57M
    +90.3%
    $3.64M
    -80.8%
    $31.50M
    +18.1%
    Strengthening
    EPS
    $0.20
    $0.11
    $0.16
    $0.43
    +115.0%
    $0.02
    -81.8%
    $0.18
    +12.5%
    Weakening
    Other Income
    Interest
    Depreciation
    Profit before Tax
    $38.81M
    $161.09M
    $27.78M
    $40.21M
    $44.59M
    +14.9%
    $26.32M
    -83.7%
    $3.98M
    -85.7%
    $46.47M
    +15.6%
    Weakening
    MarginsOPM
    12.6%
    59.1%
    7.9%
    12.2%
    12.8%
    +1.5%
    6.1%
    -89.6%
    -1.7%
    -121.8%
    12.3%
    +0.4%
    Weakening
    Tax
    15.6%
    10.8%
    31.6%
    33.7%
    -61.0%
    -491.5%
    -939.4%
    -8822.7%
    8.6%
    -72.7%
    32.2%
    -4.3%
    Weakening
    ReturnsROIC
    -1.8%
    -8.1%
    -1.1%
    -1.5%
    -4.0%
    -119.1%
    -15.4%
    -90.3%
    -0.2%
    +80.8%
    -1.8%
    -18.1%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$134.76M$189.68M$326.03M$147.44M$114.85M$188.66M$319.59M$177.69M$384.99M
    Short-Term Investments
    Total Current Assets$526.11M$760.25M$717.62M$617.82M$507.94M$616.13M$938.32M$1.06B$1.22B
    Net PP&E$3.31M$12.70M$56.44M$66.31M$61.59M$56.47M$50.79M$54.87M$86.53M
    Goodwill
    Intangibles$4.06M$2.58M$1.11M$0$0$65.49M$119.78M$108.89M$103.45M
    Total Assets$540.20M$783.18M$782.62M$700.12M$587.81M$748.96M$1.19B$1.56B$1.74B
    LiabilitiesTotal Current Liabilities$59.56M$74.83M$105.97M$96.07M$125.63M$254.25M$394.87M$277.11M$361.44M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$6.36M$44.46M$56.13M$52.70M$47.80M$42.04M$40.55M$59.55M
    Total Liabilities$61.12M$84.05M$155.61M$159.23M$187.40M$317.20M$454.96M$336.81M$436.29M
    EquityCommon Stock & APIC$14.0K$15.0K$16.0K$16.0K$16.0K$16.0K$16.0K$16.0K$16.0K
    Retained Earnings-$1.47B-$1.70B-$1.99B-$2.15B-$2.37B-$2.43B-$2.20B-$1.81B-$1.78B
    Total Equity$479.08M$699.13M$627.01M$540.89M$400.41M$431.75M$732.79M$1.23B$1.31B
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$167.47M-$151.13M-$136.17M-$125.66M-$114.03M$16.70M$157.72M$109.84M$160.32M
    Cash from Investing-$71.49M-$165.84M$192.51M-$71.10M$73.24M$32.00M-$30.54M-$302.56M-$77.47M
    Cash from Financing$306.65M$371.85M$81.00M$18.16M$8.20M$25.13M$6.84M$49.88M$46.81M
    SummaryCapital Expenditure-$2.10M-$1.13M-$7.59M-$1.12M$0-$50.0K-$523.0K-$4.69M-$14.69M
    Free Cash Flow-$169.57M-$152.26M-$143.75M-$126.78M-$114.03M$16.65M$157.20M$105.15M$145.63M
    FCF Margin-75.8%-44.9%-32.5%-26.2%-22.0%2.3%16.4%9.8%12.8%

    Ratios